EP0873349A4 - Endothelmonozyten aktivierenden ploypeptid. - Google Patents

Endothelmonozyten aktivierenden ploypeptid.

Info

Publication number
EP0873349A4
EP0873349A4 EP95923777A EP95923777A EP0873349A4 EP 0873349 A4 EP0873349 A4 EP 0873349A4 EP 95923777 A EP95923777 A EP 95923777A EP 95923777 A EP95923777 A EP 95923777A EP 0873349 A4 EP0873349 A4 EP 0873349A4
Authority
EP
European Patent Office
Prior art keywords
endothelial
activating polypeptide
polypeptide iii
monocyte activating
monocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95923777A
Other languages
English (en)
French (fr)
Other versions
EP0873349A1 (de
Inventor
Timothy A Coleman
Henrik S Olsen
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0873349A1 publication Critical patent/EP0873349A1/de
Publication of EP0873349A4 publication Critical patent/EP0873349A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP95923777A 1995-06-07 1995-06-07 Endothelmonozyten aktivierenden ploypeptid. Withdrawn EP0873349A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007328 WO1996040719A1 (en) 1995-06-07 1995-06-07 Endothelial-monocyte activating polypeptide iii

Publications (2)

Publication Number Publication Date
EP0873349A1 EP0873349A1 (de) 1998-10-28
EP0873349A4 true EP0873349A4 (de) 2001-03-14

Family

ID=22249285

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95923777A Withdrawn EP0873349A4 (de) 1995-06-07 1995-06-07 Endothelmonozyten aktivierenden ploypeptid.

Country Status (5)

Country Link
EP (1) EP0873349A4 (de)
JP (1) JP3759168B2 (de)
AU (1) AU2821695A (de)
CA (1) CA2221821A1 (de)
WO (1) WO1996040719A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885798A (en) * 1996-08-28 1999-03-23 Incyte Pharmaceuticals, Inc. DNA encoding a monocyte activating cytokine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009180A1 (en) * 1993-09-29 1995-04-06 The Trustees Of Columbia University In The City Of New York Endothelial monocyte activating polypeptide ii: a mediator which activates host response

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009180A1 (en) * 1993-09-29 1995-04-06 The Trustees Of Columbia University In The City Of New York Endothelial monocyte activating polypeptide ii: a mediator which activates host response

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BIOPOLIMERY I KLETKA, vol. 7, no. 5, 1991, pages 33 - 36, ISSN: 0233-7657 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1988, KORNELYUK A I ET AL: "TYROSYL TRANSFER RNA SYNTHETASE FROM BEEF LIVER PURIFICATION AND PHYSICO-CHEMICAL PROPERTIES", XP002152421, Database accession no. PREV198886058046 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1991, RIBKINSKA T A ET AL: "AN IMMUNOCHEMICAL APPROACH FOR STUDYING THE STRUCTURE OF TYROSYL-TRNA SYNTHETASE FROM BOVINE LIVER", XP002152422, Database accession no. PREV199294027274 *
DATABASE EMBL 2 December 1998 (1998-12-02), LEVANTES O.V. ET AL.: "Bos taurus tyrosyl t-RNA synthetase (TyrRS) mRNA, complete cds.", XP002152423 *
DATABASE EMBL 23 April 1994 (1994-04-23), HILLIER, L. ET AL.: "The WashU-Merck EST Project", XP002152018 *
DATABASE EMBL 8 December 1997 (1997-12-08), KLEEMAN, TA ET AL.: "Human tyrosyl-tRNA synthetase mRNA, complete cds." *
KLEEMAN, TA: "Human tyrosyl-tRNA synthetase shares amino acid sequecne homology with a putative cytokine", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 22, 30 May 1997 (1997-05-30), pages 14420 - 14425, XP002152017 *
MOLEKULYARNAYA BIOLOGIYA (MOSCOW), vol. 22, no. 1, 1988, pages 176 - 186, ISSN: 0026-8984 *
See also references of WO9640719A1 *
WAKASUGI KEISUKE AND PAUL SCHIMMEL: "Two distinct cytokines released from a human aminoacyl-tRNA synthetase.", SCIENCE (WASHINGTON D C), vol. 284, no. 5411, 2 April 1999 (1999-04-02), pages 147 - 151, XP002152420, ISSN: 0036-8075 *
WOLFSON A D ET AL: "Purification of mammalian tyrosyl-tRNA synthetase by high-performance liquid chromatography.", JOURNAL OF CHROMATOGRAPHY, vol. 503, no. 1, 9 March 1990 (1990-03-09), pages 277 - 281, XP000943307 *

Also Published As

Publication number Publication date
JP3759168B2 (ja) 2006-03-22
EP0873349A1 (de) 1998-10-28
JPH11507506A (ja) 1999-07-06
AU2821695A (en) 1996-12-30
WO1996040719A1 (en) 1996-12-19
CA2221821A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
GB9525474D0 (en) Antifungal proteins
EP0804469A4 (de) Neue peptide
GB9500601D0 (en) Modified peptides
GB9510830D0 (en) Proteins
PL318017A1 (en) Peptides
GB9414833D0 (en) Polypeptide
HUP9603537A3 (en) Peptides having immunmodulator influences
EP0746565A4 (de) Mit bombesin verwandte peptide
GB9425380D0 (en) Peptides
GB9324013D0 (en) Polypeptides
GB9519865D0 (en) Protein
GB9519511D0 (en) Peptides
GB9622436D0 (en) Protein
EP0873349A4 (de) Endothelmonozyten aktivierenden ploypeptid.
GB9425381D0 (en) Peptides
GB9514580D0 (en) Polypeptide
GB9514835D0 (en) Polypeptide
GB9511092D0 (en) Peptides
GB9505924D0 (en) Peptide
GB9519218D0 (en) Peptide factor
GB9502138D0 (en) Proteins
GB9524341D0 (en) Proteins
GB9516227D0 (en) Re-textured protein
GB9522660D0 (en) Protein
GB9511729D0 (en) Protein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971217

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010123

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030916

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060315